Clinical Trial Update: Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa [Phase 4]

View source ↗

Summary

Phase 4 trial updating dosing for intralesional triamcinolone in hidradenitis suppurativa; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Triamcinolone (triamcinolone)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Hidradenitis Suppurativa | Phase 4 | Status: TERMINATED | Results posted: 2023-11-13